دورية أكاديمية

Hand bone loss in early rheumatoid arthritis during a methotrexate-based treat-to-target strategy with or without adalimumab—a substudy of the optimized treatment algorithm in early RA (OPERA) trial

التفاصيل البيبلوغرافية
العنوان: Hand bone loss in early rheumatoid arthritis during a methotrexate-based treat-to-target strategy with or without adalimumab—a substudy of the optimized treatment algorithm in early RA (OPERA) trial
المؤلفون: Ørnbjerg, L. M., Østergaard, M., Jensen, T., Hørslev-Petersen, K., Stengaard-Pedersen, K., Junker, P., Ellingsen, T., Ahlquist, P., Lindegaard, H., Linauskas, A., Schlemmer, A., Dam, M. Y., Hansen, I., Lottenburger, T., Ammitzbøll, C. G., Jørgensen, A., Krintel, S. B., Raun, J., Hetland, M. L., Slot, Ole, Nielsen, Lars Kjær, Skjødt, Henrik, Majgaard, Ole, Lorenzen, Tove, Horn, Hans Christian, Kowalski, Marcin, Johansen, Inger Lauge, Pedersen, Peter Mosborg, Manilo, Natalia, Bliddal, Henning, OPERA Study Group
المصدر: Clinical Rheumatology: Journal of the International League of Associations for Rheumatology. April 2017 36(4):781-789
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:07703198
14349949
DOI:10.1007/s10067-016-3489-1